Environmental contamination with hexavalent chromium (CrVI) is a growing problem both in the United States and developing countries. Hexavalent chromium is widely used in numerous industries. Environmental exposure to CrVI adversely affects pregnancy outcomes and subsequent health of 2 generations, resulting in higher pregnancy loss, spontaneous abortion and low birth rate. Pregnant women exposed to CrVI through occupational settings experience increased risk of spontaneous abortion, stillbirth, preterm birth, and neonatal death. Children of the CrVI exposed women experience respiratory problems, perinatal jaundice, and increased birth defects. Because placental dysfunction may have a role in such adverse pregnancy outcome, we tested the hypothesis that environmental Cr exposure in pregnant women results in Cr accumulation in the human placenta, which could increase placental oxidative stress by disrupting antioxidant machinery and inducing apoptosis. Studies using frozen, deidentified human term placenta samples indicated that: (1) Cr accumulates in human term placenta tissues and (2) increase in Cr accumulation is positively correlated with oxidative stress and apoptotic markers, and altered antioxidants levels. Interestingly, there was a sexual dimorphism in the correlation between Cr accumulation and oxidative stress, and expression of apoptotic and antioxidant markers. Mechanistic in vitro studies using human trophoblast cells BeWo confirmed the detrimental effects of Cr in altering antioxidant genes. For the first time, this study provides evidence in support of a positive correlation between Cr accumulation in the human placenta and accelerated oxidative stress, with a gender bias toward the male sex.
industrial workers in the United States and several millions worldwide (Chervona and Costa, 2013) . The Blacksmith Institute has reported the "Top 10 world's worst polluted places" which include Bangladesh, China, and India for their drinking water heavily contaminated with CrVI (BlacksmithInstitute, 2007) . The deposition of CrVI wastes in landfills and waterways by chromate industries affects millions of people drinking Cr-containing water, residing in the vicinity of dangerously polluted sites. Approximately, 300 000 workers are severely affected by the Cr compounds annually around the globe (Tchounwou et al., 2012) . Non-occupational sources of CrVI include contaminated soil, air, and water (O'Brien et al., 2003) . Of relevance, significant contamination with CrVI has been found in approximately 30% of the drinking water sources in California (Salnikow and Zhitkovich, 2008) .
Health implications due to exposure to toxic heavy metals, including Cr in the environment have risen in recent years (Jaishankar et al., 2014; Jomova and Valko, 2011; Junaid et al., 2016a,b; Tchounwou et al., 2012) . Hexavalent chromium causes dermatitis, skin, lung and throat cancers, and infertility (Teklay, 2016) . Increased incidences of preterm labor and stillbirth in women and developmental defects among children living around tanneries and chrome and leather industries are evident in the developing world as well as in the United States (BlacksmithInstitute, 2007; Remy et al., 2017) . Occupational exposure to CrVI has been found to induce intrauterine growth restriction (IUGR) and low birth weight offspring (Quansah and Jaakkola, 2009) . Recent epidemiological and clinical data (Remy et al., 2017) indicate that environmental exposure to CrVI not only lead to adverse pregnancy outcomes evident as pregnancy loss, spontaneous abortion, and low birth rate but also affects the health of subsequent 2 generations. Children (F1 offspring) of the CrVI exposed women experienced respiratory problems, perinatal jaundice, and increased birth defects (Remy et al., 2017) . This first report of the detrimental reproductive effects of environmental (non-occupational) CrVI exposure in human females and their infants in the United States was deciphered using data released from the hospital records that included newborn records from 29 311-unexposed (control) and 5036-exposed, as well as 31 444-unexposed (control) and 5558-exposed pregnant women (Willits population) living in Willits, California (Remy et al., 2017) . Another epidemiological birth cohort study from Hubei province, China, evaluated the association between maternal Cr exposure during pregnancy and the risk of preterm birth among 7290 pregnant women (Pan et al., 2017) . Strikingly, this study found that maternal exposure to higher CrVI levels during pregnancy increased the risk of delivering preterm infants, particularly male infants suggestive of sexual dimorphism in the effects of Cr (Pan et al., 2017) . The mechanisms by which Cr leads to poor pregnancy outcomes remains to be determined.
Because, the placenta is the vascular interface between the mother and fetus that regulates nutrient, oxygen, and waste exchange, the poor pregnancy outcomes and IUGR following Cr exposure might be a consequence of placental dysfunctions. Several studies indicate that adverse pregnancy conditions including IUGR and preeclampsia originate from placental dysfunctions (Burton and Jauniaux, 2004; Cetin and Alvino, 2009 ). Due to the nature of this organ, the placenta has the potential to act as a gateway for chemicals and toxicants to cross and produce adverse effects within the fetus and restrict fetal growth and development. Studies have shown heavy metals such as Hg, Cd, Pb, and Cr to accumulate in placenta (Guo et al., 2010) . Accumulation of Cd in human placenta has been found to influence the transport of micronutrients to the fetus . A mother-child cohort study from Bangladesh had shown that women exposed to arsenic (As) during early gestation increases urinary 8-oxo-7, 8-dihydro-2 0 -deoxyguanosine, a marker of oxidative DNA damage (Engstrom et al., 2010) . Protein expression of 8-oxoguanine, a mutagenic oxidative damage product of guanine, was found to be increased in the cytotrophoblasts, syncytiotrophoblasts, and capillary endothelium of the placenta of As-exposed women (Engstrom et al., 2010 is produced, with the depletion of antioxidant enzymes culminating in increased oxidative stress (Standeven and Wetterhahn, 1991) . We have identified oxidative stress as one of the major pathways for CrVI-induced male (Kumar et al., 2017) and female reproductive toxicity (Banu et al., 2016; Stanley et al., 2013 Stanley et al., , 2014 ) in a rat model. However, there is no report on the impact of Cr on placental oxidative stress in the human. Although IUGR and preterm labor are predominant health issues in women exposed to CrVI, and preterm labor of the male fetuses is predominant compared with female fetuses in women exposed to CrVI in the occupational settings (Pan et al., 2017) , human exposure studies are scarce relative to environmental Cr exposure and placental function. As such, determining the mechanism of CrVI-induced oxidative damage and/or antioxidant imbalance on the human placenta are imperative to understand the mechanism by which CrVI disrupts placental function and identify strategies to mitigate adverse effects of CrVI on fetal development. Therefore, we hypothesize that environmental Cr exposure in pregnant women results in Cr accumulation in the human placenta, which could increase placental oxidative stress by disrupting antioxidant machinery and inducing apoptosis in a sexually dimorphic manner. The hypothesis was tested by: (1) determining Cr accumulation or burden in human term placenta samples; (2) identifying if there is a correlation between Cr burden and increase in oxidative stress; and/or levels and activities of endogenous antioxidant enzymes in the placenta; (3) assessing if there is a correlation between Cr burden and placental apoptosis, and (4) evaluating if these changes are sex-dependent.
MATERIALS AND METHODS

Chemicals
Reagents used in this study were purchased from SigmaAldrich, St Louis, Missouri or Thermo Fisher Scientific Inc, Austin, Texas. Details of primer sequences are given in Table 1 . 
Chromium Estimation in Placenta Samples
Placenta fragments from 3 different regions of the (same) placenta were chosen for Cr estimation. Cr content in each of the 3 placental tissue samples were determined by inductively coupled plasma mass spectrometry (ICP-MS) at Texas A&M University Trace Element Research Laboratory (Zadorozhnaja et al., 2000) . For measures of Cr concentrations, placental tissue samples were transferred to polyethylene cryotubes and digested with nitric acid and hydrogen peroxide. Digestates were transferred to 15 ml polypropylene centrifuge tubes and diluted with deionized water. Digestates were diluted to obtain a nitric acid concentration of 2% or less and then analyzed by ICP-MS on a Perkin Elmer DRC II instrument. To eliminate interferences from molecular ions, 52Cr is analyzed in "reaction cell mode" using ammonia as a reaction gas. Internal standards (eg, 89Y, 115In) were used to compensate for instrument performance changes and slight differences in viscosity and surface tension between samples and standards. Calibration was based on a blank and 4 standards and was verified initially by analyzing independent standards and regularly through the analytical process by analyzing a midrange standard and a blank. Laboratory quality control samples include a blank, a spiked blank, a certified reference material, a duplicate sample, and a spiked sample to evaluate background contamination, accuracy, and precision. For each placenta, average of Cr estimates from the 3 different regions was calculated and this average used for relating to placental function. (Veiga-Lopez et al., 2015; Vivekanandan-Giri et al., 2011) . Briefly, the placental tissue proteins were precipitated with ice-cold trichloroacetic acid (10% vol/vol) and then delipidated with water/methanol/water-washed diethyl ether
(1:3:7; vol/vol/vol). Known amounts of isotopically labeled internal standards 13C6-Y and 13C6-NY, 13C6-ClY, and 13C12-o, o'-DiY were added. After solid-phase extraction, the oxidized amino acids were quantified by HPLCESI-MS/MS with multiple reaction monitoring by integrating peak areas of the labeled standards and the analytes. The levels of the oxidized amino acids were then normalized to the precursor amino acid tyrosine content. The levels of oxidized tyrosine products are expressed as the ratio of the oxidized product over the total tyrosine. Intraassay coefficients of variation for ClY, DiY, and NiY were 2.42%, 3.31%, and 2.7%, respectively.
Real-Time RT-PCR
Total RNA was isolated using RNeasy Micro Kit (Cat. No. 74004, Qiagen) according to manufacturer's instructions. The purity and concentration of RNA were determined spectrophotometrically by measuring the absorbance at 260/280 nm and a purity of 1.8-2.0 was considered acceptable for the real-time reverse transcription (RT)-PCR analysis. Further, the Agilent 2100 Bioanalyzer System that provides an assessment of RNA intactness analyzed the quality of RNA. The RNA integrity number (RIN) was calculated with Agilent 2100 expert software. Those samples that had a RIN number of approximately ! 8 were included for mRNA expression analysis by RT-PCR. The first strand cDNA was synthesized using 100 ng total RNA by QuantiTect RT kit (Cat. 205311, Qiagen) according to manufacturer's instructions. Real-time PCR was performed using the Power SYBR Green master mix (Cat. 4368577, Life Technologies) according to manufacturer's instructions. cDNA (2 ll) was mixed with 10 ll master mix (dNTP mix, AmpliTaq Gold DNA polymerase, optimized buffer components, and SYBR Green I dye), sense and antisense oligonucleotide primers for respective genes and b-actin gene for internal control, with the total reaction volume made up to 20 ml with RNase free water. The reaction cycles were as follows: PCR enzyme initial activation at 95 C for 15 min; initial denaturation at 94 C for 15 s, annealing at 60 C for 30 s, and elongation at 72 C for 30 s. All reactions were run in triplicate. The PCR amplification of all transcripts was performed on the step-one plus real-time PCR machine (Life Technologies, Carlsbad, California). The fold differences (DDCt) were calculated by normalizing the relative expression of gene of interest with b-actin and the results expressed as fold changes. Details of the sense and antisense oligonucleotide primer sequences used for the real-time PCR analysis were given in Table 2 . All currently available nucleotide sequences encoding each gene analyzed in this study in the human were downloaded from the GenBank database. Primers were designed using the DNasis software, and commercially synthesized and obtained from Integrated DNA Technologies (Coralville, Iowa).
Protein Extraction and Immunoblotting
Protein from human placenta samples was isolated and immunoblotting/Western blotting was performed as described previously (Banu et al., 2011) . Briefly, cells were harvested using 1% Trypsin-EDTA and pelleted. Cell lysates were sonicated in sonication buffer which consisted of 20 mM Tris-Hcl, 0.5 mM EDTA, 100 mM DEDTC, 1% Tween, 1 mM phenylmethylsulfonyl fluoride, and protease inhibitor cocktail tablets: complete EDTA-free (1 tablet/50 ml) and PhosStop (1 tablet/10 ml). Sonication was performed using a Microson ultrasonic cell disruptor (Microsonix Incorporated, Farmingdale, New York). Protein concentration was determined using the Bradford method and a Bio-Rad Protein Assay kit. Protein samples (75 mg) were resolved using 7.5%, 10%, or 12.5% SDS-PAGE. Chemiluminescent substrate was applied according to the manufacturer's instructions (Pierce Biotechnology, Rockford, Illinois). The blots were exposed to Blue X-Ray film and densitometry of autoradiograms was performed using an Alpha Imager (Alpha Innotech Corporation, San Leandro, California).
Estimation of Antioxidants Activities
Glutathione peroxidase assay. A commercial kit (Cayman; Cat No. 703102) was used to measure the GPx levels according to the manufacturer's protocol. The kit measures the GPx activity indirectly by a coupled reaction with GR. Oxidized glutathione (GSSG), produced upon reduction of hydroperoxide by GPx, is recycled to its reduced state by GR and NADPH. The oxidation of NADPH to NADP þ is accompanied by a decrease in absorbance at 340 nm (Stanley et al., 2013) .
Catalase assay. The catalase activity was measured using a commercial kit (Cayman; Cat No. 707002) . In this assay, catalase reacts with methanol in the presence of H 2 O 2 to produce formaldehyde, which is then measured by adding 4-amino-3-hydrazino-5-mercapto-1, 2, 4-triazole (Purpald) as the chromogen to form a purple reaction product that can be detected spectrophotometrically at 540 nm (Stanley et al., 2013) .
Superoxide dismutase assay. A commercial kit (Cayman; Cat No. 706002) was used to measure the SOD activity according to the manufacturer's protocol. The kit utilizes the interaction between hypoxanthine and xanthine oxidase to produce O À 2• radicals, which are detected using tetrazolium salt and can be read at 460 nm. The kit detects all 3 types of SOD metalloenzymes: copper/zinc, manganese, and iron. One unit of SOD is defined as the amount of enzyme required to dismutate 50% of the O C in a humidified atmosphere containing 95% air/5% CO 2 . Cells were plated in 75 cm 2 flask and incubated overnight. The following day, the medium was removed and replaced by fresh F-12K Medium supplemented with 10% fetal bovine serum. When the cells reached 60%-70% confluency, the media was replaced with F-12K Medium with 2% steroidstripped serum. After 24 h, cells were treated with CrVI (potassium dichromate) 0, 0.5, 5, 10, 15, 20, 30, and 50 mM for 24 h in triplicates. Total RNA was isolated as described earlier for human placenta for further analyses. Rationale for CrVI dose-selection: LD50 of CrVI in BeWo cells is 30.17 mM. The doses of CrVI selected for treating the BeWo cells was based on the low and high levels of Cr measured in the human placenta samples. Low-Cr group of human placentae had accumulated 0.02-0.075 ppm Cr, which is equivalent to 0.3-1.125 mM. High-Cr group of human placentae had accumulated 1.0-1.25 ppm Cr, which is equivalent to 9.1-11.38 mM. The CrVI doses (0.5-30 mM) used in BeWo cell culture cover the range measured in the human placental samples and higher to account for occupational exposure levels.
Statistical Analysis
All quantitative data were analyzed by ANOVA (SAS Institute, Cary, North Carolina) followed by Tukey's HSD Test procedures. Correlation between Cr levels in the human placenta and expression of antioxidant genes or proteins, or apoptotic and cell survival proteins were analyzed using Pearson correlation coefficient. Least squares regression analysis was used to determine effects of treatment (Control, CrVI 5, 15, and 30 mM); time (CrVI 12 h, CrVI 24 h) and treatment Â time interactions in studies involving the BoWo cells. Numerical data are presented as means with standard errors. Statistical significance was considered as P < .05.
RESULTS
Cr Accumulates in the Human Term Placenta Figure 1A shows the levels of Cr in each placenta sample (n ¼ 25 male and n ¼ 25 female). Detectable levels of Cr were found in all the 50 human placenta samples, ranging from 0.02 to 1.2 ppm. As shown in Figure 1B , out of the 25 placental samples from each sex, 4 groups were chosen for further analyses as follows: group 1 (S1-S5): low-Cr male (n ¼ 5): 5 placenta samples from male fetuses that had lowest concentrations of Cr (0.02-0.05 ppm); group 2 (S6-S10): high-Cr male (n ¼ 5): 5 placenta samples from male fetuses that had highest concentrations of Cr (1.15-1.25 ppm); group 3 (S11-S15): low-Cr female (n ¼ 5): 5 placenta samples from female fetuses that had lowest concentrations of Cr (0.05-0.07 ppm); and group 4 (S16-S20): and high-Cr female (n ¼ 5): 5 placenta samples from female fetuses that had highest concentrations of Cr (1.0-1.15 ppm).
Increased Accumulation of Chromium Elevates Oxidative Stress Markers in Human Term Placenta
To relate placental Cr burden to oxidative stress, levels of oxidative stress markers DiY, ClY, and NiY were determined in the 5 high-Cr and 5 low-Cr placentae in each sex. DiY is a marker for hydroxyl radical, peroxynitrite, and peroxidase oxidation, ClY is a specific marker of myeloperoxidase pathway, and NiY is a marker for nitrosative stress (Vivekanandan-Giri et al., 2011). DiY ( Figure 2A ) and NiY ( Figure 2B ) but not ClY ( Figure 2C ) levels were elevated in high-Cr placentae of male and female fetuses compared with low-Cr placentae. Interestingly, DiY from highCr was significantly higher in males compared with females. Similarly, NiY levels in both low-and high-Cr groups were 2-fold higher in males than in females, indicating an increase in oxidative stress in males compared with females ( Figure 2B ).
Increased Accumulation of Chromium Alters mRNA and Protein Levels and Activities of Antioxidants in Human Term Placenta
In placenta associated with male fetuses, there were significant decreases in the mRNA and protein levels of GPX1, catalase, PRDX3, and TXN2 in high-Cr group compared with low-Cr group. In contrast, SOD1 but not SOD2 was significantly increased in high-Cr group compared with low-Cr group (Figs. 3A-F and 4A-F). In placenta associated with female fetuses, GPX1, SOD2, PRDX3, and TXN2 mRNA and proteins were decreased, there was no change in catalase, and SOD1 increased in high-Cr group compared with low-Cr group (Figs. 3A-F and 4A-F). Overall, increase in Cr accumulation in placental tissue was significantly associated with decreased antioxidant levels. There was sexual dimorphism in the levels of antioxidant proteins with SOD1 and PRDX3 being more abundant in females than males (Figs. 3 and 4C and 4E); whereas, GPX1 (only the protein level), SOD2, and TXN2 were more abundant in males than females (Figs. 3 and 4A, 4D, and 4F). There were no changes in beta actin gene or protein ( Figure 4G ) expression due to Cr exposure. Further, we measured activities of 3 major antioxidants in the placenta, namely, GPX, catalase, and SOD. In male placenta, activities of GPX and catalase decreased in high-Cr group compared with low-Cr, whereas, SOD activity significantly increased in high-Cr group compared with low-Cr group (Figs. 5A-C) . In female placenta, activities of GPX decreased, SOD increased, and catalase did not change. Although the GPX activity was higher in the male placenta, catalase and SOD activities were elevated in the female placenta (Figs. 5B and 5C).
Sexual Dimorphism in the Expression Patterns of Cell Survival or Apoptotic Proteins and Their Association With Chromium Accumulation
In placenta with male fetuses, apoptotic proteins such as cytochrome C, cleaved-caspase-3, apoptosis inducing factor (AIF), BAX, and p53 were significantly elevated in high-Cr group compared with the low-Cr group (Figs. 6A-E) . On the other hand, cell survival proteins BCL2 and BCL-XL were elevated (Figs. 6F and 6G); and X-linked inhibitor of apoptosis (XIAP) was significantly decreased ( Figure 6H ) in high-Cr group compared with low-Cr group. In the placenta with female fetuses, apoptotic proteins such as cytochrome C, cleaved-caspase-3, AIF, and BAX were significantly elevated in high-Cr group compared with the low-Cr group (Figs. 6A-D) . Interestingly, there was no significant difference in the expression of p53 between highand low-Cr groups ( Figure 6E ). On the other hand, cell survival proteins BCL2 and BCL-XL were elevated (Figs. 6F and 6G) in high-Cr group compared with low-Cr group. There was no change in XIAP ( Figure 6H ) between high-and low-Cr groups. Overall, in both the sexes, increase in Cr accumulation in placental tissues was significantly associated with elevated apoptotic proteins. In particular, there was a clear sexual dimorphism in the expression patterns of different proteins in high-Cr group compared with low-Cr groups. In male placenta, p53 was remarkably elevated (8-folds higher) compared with females. Whereas in female placenta, XIAP (2-folds) and caspase-3 (3-folds) were significantly increased compared with male placentae in high-Cr group. There were no changes in beta actin gene or protein expression ( Figure 6I ) due to Cr exposure.
Dose Response of CrVI on Antioxidants in Human Trophoblast
Cell Line BeWo Figure 7 shows a CrVI dose-response curve of BeWo cells. LD50 of CrVI in BeWo cells is 30.17 mM. mRNA expression of antioxidants were performed with 5, 15, and 30 mM CrVI, treated for 12 or 24 h. GPX1 mRNA was significantly increased with low dose (5 mM) CrVI treatment after 12 h, and decreased after 24 h. Higher doses of CrVI (15 and 30 mM) decreased GPX1 expression after 12 and 24 h ( Figure 8A ). SOD1 mRNA expression also showed a similar trend as GPX1 ( Figure 8C ). Catalase and SOD2 mRNA levels were dose-dependently decreased by CrVI treatment (5, 15, and 30 mM) after 12 and 24 h (Figs. 8B and 8D) ; however, PRDX3 and TXN2 did not change with 5 mM CrVI treatment after 12 h but decreased after 24 h. Higher doses of CrVI treatment (15 and 30 mM) significantly decreased PRDX3 and TXN2 mRNA expressions in both 12 and 24 h time points (Figs. 8E and 8F) . scribed under Materials and Methods. B, Five male placenta samples with the lowest Cr concentration (group 1) (low-Cr, S1-S5) and the highest Cr concentration (group 2) (high-Cr, S6-S10), and 5 female placenta samples with the lowest Cr concentration (group 3) (low-Cr, S11-S15) and with the highest Cr concentration (group 4) (highCr, S16-S20) are shown. Each value is mean 6 SEM of 3 fragments of placenta from 3 locations of the same specimen, P < .05. 
DISCUSSION
Findings from this study document the presence of varying levels of Cr in the human term placentae and their positive association with oxidative stress markers and key proteins of the apoptotic machinery, and negative correlation with antioxidants. Strikingly, a sexual dimorphism in the association between levels of Cr and the expression patterns of various antioxidants and apoptotic and cell survival proteins were evident. The relevance of the impact of placental Cr burden in increasing oxidative stress and apoptotic markers as it relates to placental function and pregnancy outcome are discussed later. In addition, in vitro studies with BeWo cells provide support for a causal relationship between increased Cr levels and decrease in antioxidants. It should be recognized that the BeWo cell line, while suitable to assess the effects of Cr burden on antioxidants machinery, is not an ideal model to validate the sexually dimorphic responses of the placenta to Cr burden. Future studies with primary cytotrophoblast cultures from male and female placenta are required to test sexually dimorphic responses to Cr.
Evidence of Cr Accumulation in Human Placentae
The findings from this study showed that Cr concentration in the placenta of male fetuses varied from 0.02 to 1.25 ppm, and female fetuses varied from 0.05 to 1.15 ppm. The USEPA approved safety limit for Cr levels in drinking water is 0.1 ppm (Malott, 2015) . Even though earlier epidemiological studies from Crexposed women have shown Cr accumulation in the placenta, increased incidence of premature abortions, preterm labor in pregnant women, and various developmental defects and stillbirth in children of the Cr-exposed women, the underlying mechanisms have not been investigated. Cr levels in placenta measured in this study are higher than the national regulatory dose, and closer to the range of drinking water levels of Cr in the worst contaminated places in the United States. Therefore, the outcome of this study stresses the need to revisit the regulatory policies of CrVI content in the drinking water. Association Between Cr Accumulations in Human Placentae and Increased Oxidative Stress Oxidative status of a tissue reflects the balance between oxidants and antioxidants. Our findings show that increase in Cr accumulation was associated with elevated oxidative stress markers ClY, DiY, and NiY in high-Cr group placenta compared with the low-Cr group. Other heavy metals have also been known to induce excessive production of ROS and decrease antioxidant levels in the human placenta (Ahamed et al., 2009; Gundacker and Hengstschlager, 2012; Singh et al., 2015) . A recent epidemiological study reported a positive correlation between concentrations of heavy metals such as cadmium and lead and preterm birth in women due to an increase in oxidative stress and decrease in glutathione levels (Singh et al., 2015) . Another study found increased risk of preeclampsia with increased levels of cadmium and a concomitant decrease in zinc (Laine et al., 2015) ; Zinc ameliorates cadmium toxicity (Laine et al., 2015) . Animal studies also indicate that oxidative stress in the placenta can be induced by exposure to endocrine disrupting chemicals (Banu et al., 2017b; Gundacker and Hengstschlager, 2012; Gundogan et al., 2010) . Our recent findings from a rat model, documenting impact of gestational exposure to CrVI in accelerating oxidative stress and decreasing antioxidant proteins in the various placental compartments (Banu et al., 2017b) , provide support for a causal role for Cr in inducing oxidative stress. Studies with BeWo cells, an in vitro placental cell model used in this study, also provide support for a causal role for Cr in inducing oxidative stress. The concentration of CrVI used for in vitro studies with BeWo cells was similar to the Cr burden in the placentae. Low and high levels of Cr measured in the human placentae samples were 0.02-0.07 ppm and 1.0-1.2 ppm, respectively. Cr 0.02 ppm is equivalent to 0.3 mM; Cr 1.25 ppm is equivalent to 11.38 mM. To reflect the human exposure level, we used similar range of Cr doses measured in the human placental samples with experiments in BeWo cells. Although human placenta expresses many antioxidants (Cindrova-Davies et al., 2007) , data from this study documenting significant decreases in the levels of GPX1, catalase, PRDX3, and TXN2 in high-Cr group indicate loss of antioxidant protection that is in place to overcome the deleterious effects of oxidative stress. Other studies have shown that production of autoantibodies against peroxiredoxin family members PRDX3 and PRDX4 result in recurrent spontaneous abortion in women (Gharesi-Fard, 2015) . Consistent with this, our recent study in rats found gestational exposure to CrVI decreased antioxidants culminating in IUGR (Banu et al., 2017a,b) . Although the concept that increase in oxidative stress leads to placental dysfunctions, pregnancy complications, and decrease in birth weight (Burton and Jauniaux, 2004; Hempstock et al., 2003; Richter et al., 2012 ) is well-recognized, evidence establishing a relationship between Cr accumulation and oxidative stress in the human placenta is lacking. The findings from this study provide the first documentation that increased Cr burden in the human placenta is associated with elevated markers of oxidative stress, a risk factor for poor pregnancy outcomes.
Association Between Cr Accumulation in Human Placentae and Increase in Apoptosis Marker Proteins
Our recent studies in rats found gestational exposure to CrVI increases apoptotic marker proteins by various trophoblast lineages of the placenta in a spatiotemporal manner (Banu et al., 2017a,b) . Increased apoptosis due to elevated oxidative stress markers such as that seen in this study has also been reported previously in human placenta (Kavitha et al., 2016) . Increase in oxidative stress alters mitochondrial membrane potential leading to the leakage of cytochrome-C, which activates cleavage of caspase-3 resulting in apoptosis. Hexavalent chromium induction of apoptosis in rats occurs through caspase-3-dependent pathways or p53-NOXA/PUMA-mediated mechanisms (Banu et al., 2017a) . If the same holds true for human placenta, remains to be ascertained.
Sexual Dimorphism in the Association Between Cr Accumulation and Oxidative Stress/Apoptosis Although a statistically significant difference in Cr accumulation between male and female placentae cannot be discerned in this study, a clear sexual dimorphism with a male bias was evident in the association between Cr accumulation and oxidative stress, levels of antioxidants and expression of various apoptotic markers. Many studies (Gabory et al., 2013; Stevenson et al., 2000; Vatten and Skjaerven, 2004) have reported gender specific differences in fetal growth and fetal and neonatal morbidity and mortality; number of stillbirths and neonatal deaths appear to be greater among males compared with females (Mondal et al., 2014) . Significant effects of fetal gender with a male bias on pregnancy outcome and pregnancy-related complications have been observed with regard to preterm birth, preeclampsia, gestational diabetes mellitus, nuchal cord, and true umbilical cord knots (Di Renzo et al., 2007; Gabory et al., 2013; Khalil and Alzahra, 2013) . A recent study also found increased oxidative stress in male placenta due to maternal obesity (Evans and Myatt, 2017). Interestingly, one study found maternal exposure to higher CrVI levels during pregnancy increased the risk of delivering preterm infants, particularly male infants (Pan et al., 2017) . Importantly, there appears to be normally occurring sexually dimorphic differences in antioxidant enzyme expression and activity. For instance, mitochondria from female subjects appear to generate one-half the amount of superoxide radicals than males (Balaban et al., 2005) . Male subjects have been found to have higher oxidative stress and lower levels of antioxidant enzymes such as SOD and catalase (Tomas-Zapico et al., 2006) . Higher total antioxidant status and lower plasma membrane hydroperoxides were evident in umbilical cord artery of girls compared with boys (Diaz-Castro et al., 2016) . Estradiol-induced upregulation of the expression of SOD and GPx (Viña et al., 2005) may protect against oxidative stress in females. Thus, the male preponderance in placental disorders emphasizes a critical need to understand the molecular mechanisms underlying sex bias in placental development and dysfunction. Our data clearly support the existing divergence of sex in antioxidants enzymes expression and activity.
Consistent with the reported male bias in pregnancy outcomes, in this study, oxidative stress markers were elevated, and antioxidants such as SOD1 and PRDX3 were decreased in male placentae compared with female placentae. Similarly, proapoptotic candidate protein p53 was increased, while antiapoptotic and prosurvival candidate XIAP highly decreased in male placentae compared with female placentae. Our previous studies in rats have demonstrated p53 as the major candidate for CrVI-induced apoptosis in the placenta (Banu et al., 2017a) . In contrast, cleaved-caspase-3 expression was 3-fold higher in the female placenta with high-Cr compared with male placenta. Thus, it appears that caspase-3 pathway might play a key role in apoptosis of female placenta, while p53 could be a key target for Cr in male placenta. Our data also show selective downregulation of XIAP in the male placenta with high-Cr. Decreased XIAP activation has been documented in preeclamptic placenta (Arroyo et al., 2014) . Strikingly, genetic forms of hemophagocytic lymphohistiocytosis caused by mutations in X-linked gene XIAP (Marsh et al., 2010) , are typically found only in males (Holle et al., 2015) . Thus, findings from this study are consistent with male placenta being more vulnerable to increased apoptosis due to selective upregulation of p53 and decrease in XIAP possibly due to the lack of dosage compensation. In addition, lower levels of 3 candidate proteins of the cell survival pathways, namely BCL2, BCL-XL, and XIAP, in the male placentae may also have contributed to the male bias.
To summarize, gynecological disorders such as preterm labor, early pregnancy loss, postpartum bleeding, IUGR, and stillbirth are well-known in women exposed to CrVI, with a selective preponderance in male fetuses. As depicted in the proposed (suggestive) model (Figure 9 ), the findings from this study suggests that sexually dimorphic changes in oxidative stress markers, antioxidant levels, and apoptotic markers in the placenta may underlie the sex-specific impact of Cr on adverse pregnancy outcomes. Even though, these pregnancies are considered healthy relative to birth outcomes, the impact of elevated Cr and oxidative stress and apoptosis markers in the placenta in having adverse postnatal effects on the babies is unclear. Further studies are needed to understand the longterm health impact of Cr-induced placental changes in the offspring and also to validate if these parameters could be used as the biomarkers to determine the future health outcome of the exposed children. Although the focus of this study was on Cr burden, it needs to be recognized that accumulation of other metals such as Cd, Ni, As, and Mn and other endocrine disruptors in the placenta may have also played a role in the development of such adverse effects. These studies need to be expanded to address mixture effects, a fruitful avenue for future research.
